Primary Age-Related Tauopathy in Human Subcortical Nuclei

Primary Age-Related Tauopathy in Human Subcortical Nuclei

The present study aimed to determine the spatial distribution patterns of hyperphosphorylated tau-immunoreactive cells in subcortical nuclei of post-mortem human brain with primary age-related tauopathy (PART). Subcortical tauopathy has important pathological and clinical implications. Expression of...

Full description

Bibliographic Details
Main Authors:	Keqing Zhu, Xin Wang, Bing Sun, Juanli Wu, Hui Lu, Xiaoling Zhang, Huazheng Liang, Dandan Zhang, Chong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-05-01
Series:	Frontiers in Neuroscience
Subjects:	primary age-related tauopathy subcortical nuclei Alzheimer’s disease neurofibrillary tangle brainstem brain bank
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2019.00529/full

Similar Items

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2019-12-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2020-02-01)

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
by: Geoffrey Pires, et al.
Published: (2019-12-01)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
by: Inbal Lahiani-Cohen, et al.
Published: (2020-01-01)

Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)

A Processing Pipeline for Quantifying Lenticulostriate Artery Vascular Volume in Subcortical Nuclei
by: Ning Wei, et al.
Published: (2021-08-01)

High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer’s disease using computational approaches
by: Rohit Shukla, et al.
Published: (2021-05-01)

Distinct Mechanisms Underlying Resveratrol-Mediated Protection from Types of Cellular Stress in C6 Glioma Cells
by: John C. Means, et al.
Published: (2017-07-01)

Effects of resveratrol and morin on insoluble tau in tau transgenic mice
by: Yu Kwun Chung, et al.
Published: (2018-11-01)

Fyn depletion ameliorates tauP301L-induced neuropathology
by: Guanghao Liu, et al.
Published: (2020-07-01)

Volumetric and Diffusion Abnormalities in Subcortical Nuclei of Older Adults With Cognitive Frailty
by: Mingyue Wan, et al.
Published: (2020-07-01)

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
by: Nicolas Sergeant, et al.
Published: (2019-09-01)

RNA binding proteins co-localize with small tau inclusions in tauopathy
by: Brandon F. Maziuk, et al.
Published: (2018-08-01)

Hippocampal Changes in Down’s Syndrome
by: J Gordon Millichap
Published: (1995-05-01)

Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
by: Rebecca L. Kow, et al.
Published: (2021-01-01)

Factors Associated With the Occurrence and Evolution of Recent Small Subcortical Infarcts (RSSIs) in Different Locations
by: Hui Hong, et al.
Published: (2020-08-01)

The Significance of Tau Aggregates in the Human Brain
by: Rudy J. Castellani
Published: (2020-12-01)

The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer’s Disease
by: Filippo S. Giorgi, et al.
Published: (2017-09-01)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
by: Guo YJ, et al.
Published: (2016-02-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

Research Progress in the Pathogenesis of Alzheimer's Disease
by: Yi-Gang Chen
Published: (2018-01-01)

Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L × GSK3β mice by delaying brainstem tauopathy
by: Natalia Crespo-Biel, et al.
Published: (2014-07-01)

Dynamic modulation of activity in cerebellar nuclei neurons during pavlovian eyeblink conditioning in mice
by: Michiel M ten Brinke, et al.
Published: (2017-12-01)

Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review
by: Adam D. Bachstetter, et al.
Published: (2021-03-01)

The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer’s disease
by: Cheong-Meng Chong, et al.
Published: (2019-05-01)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
by: Marta Perez-Rando, et al.
Published: (2020-10-01)

Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
by: Adrian Florian Bălașa, et al.
Published: (2020-10-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
by: Sarah Houben, et al.
Published: (2020-07-01)

In vivo quantification of neurofibrillary tangles with [18F]MK-6240
by: Tharick A. Pascoal, et al.
Published: (2018-07-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

Fluctuations in neurofibrillary tangle density in Alzheimer’s disease revealed by Fourier (spectral) analysis
by: Richard Armstrong
Published: (2021-01-01)

Differentiating Alzheimer disease-associated aggregates with small molecules
by: Nicolette S. Honson, et al.
Published: (2007-12-01)

Activation of Caspase-8 in the Alzheimer's Disease Brain
by: Troy T. Rohn, et al.
Published: (2001-12-01)

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
by: Zilka Norbert, et al.
Published: (2012-03-01)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
by: Goran Šimić, et al.
Published: (2016-01-01)

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
by: Xiao-ying Sun, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_p83tkhhnqnotdd1a6g9tm311iq